Vascular smooth muscle cells are constantly exposed to mechanical force by the blood pressure, which is thought to regulate smooth muscle growth, differentiation and contractile function. We have previously shown that the expression of microRNAs (miRNAs), small non-coding RNAs, is essential for regulation of smooth muscle phenotype including stretchdependent contractile differentiation. In this study, we have investigated the effect of mechanical stretch on miRNA expression and the role of stretch-sensitive miRNAs for intracellular signaling in smooth muscle. MiRNA array analysis, comparing miRNA levels in stretched versus non-stretched portal veins, revealed a dramatic decrease in the miR-144/451 cluster level. Because this miRNA cluster is predicted to target AMPK pathway components, we next examined activation of this pathway. Diminished miR-144/451 expression was inversely correlated with increased phosphorylation of AMPKa at Thr172 in stretched portal vein. Similar to the effect of stretch, contractile differentiation could be induced in non-stretched portal veins by the AMPK activator, AICAR. Transfection with miR-144/451 mimics reduced the protein expression level of mediators in the AMPK pathway including MO25a, AMPK and ACC. This effect also decreased AICAR-induced activation of the AMPK signaling pathway. In conclusion, our results suggest that stretch-induced activation of AMPK in vascular smooth muscle is in part regulated by reduced levels of miR-144/451 and that this effect may play a role in promoting contractile differentiation of smooth muscle cells. 
Introduction
Vascular smooth muscle cells (VSMCs) have a remarkable ability to adapt to environmental cues by phenotypic modulation [1] . This is likely a key mechanism to allow for repair following vascular injury but phenotypic modulation of smooth muscle cells can also have detrimental effects in the development of vascular disease [2] . Intense efforts have therefore been made to clarify the molecular mechanisms behind phenotypic modulation of VSMCs and to identify potential targets for therapeutic intervention in this response.
We have previously reported that mechanical stretch is an important factor for the regulation of smooth muscle phenotype using murine portal veins in organ culture [3] [4] [5] [6] [7] . In this model, portal veins are subjected to longitudinal stretch by applying a gold weight at one end of the vessel, which results in increased hypertrophic growth, remodeling and contractile differentiation over one to five days. Although multiple pathways are likely to be involved in smooth muscle mechanotransduction, stretch partly promotes growth by activating MAP-kinase/ERK and PI3-kinase/Akt, and contractile differentiation by stimulating the Rho/cofilin pathway and actin polymerization. These signaling pathways are also known to be activated in the arterial system during experimental models of hypertension [8] [9] [10] [11] [12] [13] [14] . Stretchinduced growth in the portal vein is also dependent on endogenous release of angiotensin II and endothelin-1 [3, 15] , while contractile differentiation requires calcium influx via L-type calcium channels [16, 17] .
MicroRNAs are short, non-coding RNAs that are known to regulate mRNA stability and protein translation by binding to their target mRNAs [18] . In most cases, miRNA-binding to the 39UTR of the target mRNA results in translational inhibition or mRNA degradation. In smooth muscle, the role of miRNAs has been investigated using conditional knockout of Dicer, an essential enzyme for miRNA maturation. Early embryonic deletion of Dicer in smooth muscle causes embryonic lethality due to reduced proliferation, contractile differentiation and contractile function of smooth muscle cells, which results in widespread internal hemorrhage [19] . Similar effects on smooth muscle differentiation and contractile function are observed in adult mice with inducible and smooth muscle specific deletion of Dicer [20, 21] . In a recent report, we found that inducible deletion of Dicer in smooth muscle results in loss of L-type calcium channels and reduced stretchinduced contractile differentiation of the portal vein [17] .
In the present study we hypothesized that miRNAs are regulated by mechanical factors and play a role in stretch-induced signaling events in vascular smooth muscle cells. We used portal veins in organ culture to screen for miRNAs that are regulated by mechanical stretch and found a cluster of two miRNAs, miR-144/ 451 that were significantly down-regulated and may play a role in stretch-dependent activation of the AMP-activated protein kinase (AMPK) pathway and contractile differentiation.
Materials and Methods

Ethics statement
All animal work was conducted according to national and international guidelines and approved by The Malmö/Lund ethical committee on animal experiments (M260-11).
Chemicals AICAR (AMPK activator) was purchased from Toronto Research Chemicals (TRC), #A611700 and dissolved in water to 250 mM by warming to 37uC and vortexing.
Organ culture
Adult male C57BL/6J mice (30-35 g) were euthanized by cervical dislocation. Portal veins were freed from fat and surrounding tissue and mounted on a hook in a test tube containing DMEM/Hams F12 with 2% dialyzed FCS and 10 nM insulin as described [4] . All of the blood was carefully removed from the vessels, which were either stretched by attaching a 0.3 g gold weight at one end or left non-stretched as controls. The load corresponds to the optimal load for force development. The vessels were incubated in cell culture environment from 24 hours up to 5 days.
Carotid arteries were mounted on glass cannulas in a pressure myograph chamber (Living Systems Instrumentation, Burlington, VT) and secured with silk sutures as described previously [22] . The vessels were then incubated under zero or 95 mmHg intraluminal pressure in HEPES buffer (composed of 135.5 mM NaCl, 5.9 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , 11.6 mM glucose, and 11.6 mM HEPES, pH 7.4). The vessel diameter was monitored using a Nikon Diaphot 200 inverted microscope equipped with a charge-coupled device (CCD) camera and VediView 1.2 software (Danish MyoTechnology). The intraluminal pressure was continuously monitored by two pressure transducers (one on the inflow side other on the outflow side), which were connected to a pressure servo and peristaltic pumps (Living Systems Instrumentation, Burlington, VT). The temperature was maintained at 37uC throughout the experiment.
Cell culture and transfection
Vascular smooth muscle cells were isolated from mouse aorta by enzymatic digestion as described previously [19] . Mouse aortic smooth muscle cells (mAoSMCs) were used at passages 3-5 for experiments. Cells were transfected with commercially available synthetic microRNA mimics for miR-144, miR-451 (Syn-mmumiR-144, Syn-mmu-miR-451 Qiagen or MISSION H microRNA-144 or microRNA-451 mimic, Sigma) or negative control (MISSION H microRNA negative control, Sigma) using Oligofectamine transfection reagent (Invitrogen) as described previously [19] .
MicroRNA array
Mouse portal veins were organ cultured for 24 hours either stretched our unstretched (n = 14). The portal veins were then pooled and the miRNA-enriched fraction was isolated using miRNeasy mini kit (Qiagen, #217004) and RNeasy MinElute Cleanup Kit (Qiagen, #74204) according to the manufacturer's instructions. Following reverse transcription using RT 2 miRNA First Strand Kit (SA Biosciences #331401), the expression of 528 miRNAs was analyzed using RT 2 miRNA PCR Array mouse (SA Biosciences #MAM-200C).
Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated using miRNeasy mini kit (Qiagen, #217004) according to the manufacturer's instructions. For miRNA detection 250-500 ng of template RNA was reverse transcribed to cDNA using miScript II RT Kit (Qiagen, #218161) according to the manufacturer's instructions. The relative expression of miRNAs was analyzed by real-time qPCR (StepOnePlus qPCR cycler, Applied Biosystems) using miScript SYBR Green PCR Kit (Qiagen, # 218073) and miScript Primer Assays (Mm_miR-144_3, #MS00032326; Mm_miR-451_1 # MS00002408, Hs_RNU6-2_1, #MS00033740).
For mRNA analysis, the same isolation kit, including on-column DNAse I digestion, and qPCR equipment as for miRNA was used, but mRNA expression was detected using QuantiFast SYBR Green RT-PCR Kit Qiagen, #204156) and QuantiTect primer assays (Qiagen, Mm_Kcnmb1, #QT00101500, Mm_Tagln, QT00165179, Mm_Cnn1, QT00105420, Mm_Des, #QT00102333). The qPCR primer sequences used for Mm_Myh11 have been published previously [23] .
Western blotting
Cells grown on 6-well plates were washed twice with ice-cold PBS and lysed on ice directly in the wells with 70-75 ml of 16 Laemmli sample buffer (60 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol). After protein determination with the Lowry method (BioRad reagents) bromophenol blue and b-mercaptoethanol were added to the samples at final concentrations of 0.005% and 5% respectively. Equal amounts (15-30 mg) of protein were loaded in each lane of Bio-Rad TGX 4-15% Criterion gels. Proteins were then transferred using either wet transfer over-night or semi-dry transfer for 10 min using the Trans-Blot Turbo system (Bio-Rad). Proteins were detected using commercially available primary antibodies: AMPKa (#2603), ACC (#3662), MO25a (CAB39, #2716), p70 S6 Kinase (#9202) (1:1000), T172-phospho-AMPKa (#2535), S79-phospho-ACC (#3661), T389-phospho-p70 S6 Kinase (#9234) (1:500) -Cell Signaling, GAPDH (#MAB374, Millipore, 1:1000-1:5000), HSP90 (#610418, BD Transduction Laboratories, 1:1000). Secondary mouse or rabbit HRP-conjugated antibodies (#7074, #7076 1:5000 or 1:10000, Cell Signaling) were used. Bands were visualized using ECL (Pierce West Femto) and images were acquired using the Odyssey Fc Imager (LI-COR Biosciences).
AMPK activity assay
Cell lysates containing 5-25 mg total protein were subjected to immunoprecipitation of AMPKa1 and -a2 with 1 mg of isoformspecific antibodies, kindly provided by Professor Grahame Hardie, University of Dundee. Kinase activity against a peptide substrate was then determined in vitro as described previously [24] . In short, the phosphotransferase activity was measured by incubating the immunoprecipitates for 20 min at 30uC, in a total assay volume of 50 ml, containing 50 mM Tris-HCl pH 7.5, 0.1% (v/v) 2-mercaptoethanol, 10 mM MgCl 2 , 0.1 mM EGTA, 0.1 mM [c-32 P]-ATP (300 cpm/pmol) (PerkinElmer) and 200 mM of the AMARA (AMARAASAAALARRR) peptide substrate (GL Biochem Ltd). The reaction mixture was applied onto P81 papers (Whatman), which were washed with 50 mM phosphoric acid, and the incorporated radioactivity was then quantified by scintillation counting.
Statistics
Values are presented as mean 6 S.E. unless otherwise stated. Pvalues were calculated by Student's t-test or one-way analysis of variance followed by Bonferroni post-hoc testing using GraphPad Prism 5 (GraphPad Software Inc.). P,0.05 was considered statistically significant. Data are expressed as mean 6 S.E.M. *, p,0.05; **, p,0.01; ***, p,0.001.
Results
The expression of microRNA-144/451 is down-regulated in stretched portal veins and in pressurized carotid arteries, which inversely correlates with increased expression and phosphorylation of AMPK To identify miRNAs sensitive to stretch, we performed whole genome miRNA qPCR arrays using RNA extracted from pooled mouse portal veins (n = 14) stretched for 24 h or unstretched controls and normalized to four different housekeeping genes (HKG). The analysis revealed a dramatic decrease in miR-144 and miR-451 with only minor changes (4-fold cut off) in other functional miRNAs strands including the smooth muscle specific miR-145 ( Figure 1A) . The down-regulation of miR-144 and miR-451 in stretched portal veins was then validated using individual qPCR reactions in triplicate ( Figure 1B) . Some of the miRNAs that were not affected by stretch at 24 h such as miR-1, miR-143 and miR-145 were also included in the individual miRNA analysis ( Figure 1B ). In accordance with the effect in portal veins, pressurization of carotid arteries for 6 hours resulted in decreased expression of miR-144/451 ( Figure 1C ).
An analysis of predicted targets of miR-451 and miR-144 revealed MO25a (Cab39) and AMPKa1 (Prkaa1), respectively ( Figure 1D ). Both MO25a and AMPKa are involved in the regulation of the AMPK pathway, a central regulator of cellular metabolism. Furthermore, AMPK has been demonstrated to be activated by AngII [25] and to play an important role in prevention of neointimal hyperplasia [26, 27] .
In order to investigate the effect of stretch on AMPK signaling we analyzed phosphorylation of AMPKa in stretched versus nonstretched portal veins. Phosphorylation at Thr172, which governs AMPK activity, was significantly increased in portal veins stretched for 5 days both when compared to total AMPKa expression levels ( Figure 1E and H) and to GAPDH ( Figure 1F and H). Total AMPKa protein content was increased after 5 days of stretch ( Figure 1G and H), inversely correlating with the downregulated levels of miR-144 and miR-451 in these vessels. No significant change in either AMPK phosphorylation or AMPK protein content was detected in stretched portal veins after 2 days of organ culture.
Transfection of miR-144/451 mimics leads to a downregulation of AMPKa/MO25a/ACC protein expression in primary VSMCs
To evaluate the effect of miR-144 and miR-451 on the expression of mediators in the AMPK pathway, we transfected primary VSMCs isolated from mouse aorta with miRNA mimics either separately or in combination. The expression levels of both miRNAs were very low in cultured cells compared to intact smooth muscle (Suppl. Figure S1A and B) and therefore we did not attempt to inhibit these miRNAs using miRNA inhibitors. qPCR analysis confirmed that the miR-144 or miR-451 expression level in cells transfected with the respective miRNA mimic was significantly higher than in the cells transfected with negative control (data not shown). Both mimics were used at 100 nM concentration, which was chosen based on dose-response experiments (data not shown).
MO25a, which is a scaffolding protein required for full activity of the upstream AMPK kinase -LKB1, has previously been experimentally validated as a target of miR-451 in glioma cells [28] and cardiac myocytes [29] . In accordance with these studies we found a down-regulation of this protein following transfection of miR-451 mimic in primary VSMCs (Figure 2A) . Furthermore, transfection of either miR-144 or miR-451 mimic down-regulated the protein expression of AMPKa ( Figure 2B ). Unexpectedly transfection with miR-451 also affected the protein expression of acetyl-CoA carboxylase (ACC), which is a downstream mediator of the AMPK pathway.
Transfection of miR-451 and miR-144 mimics reduces AICAR-induced activation of the AMPK pathway
In order to evaluate the importance of miR-144 and miR-451 for the activity of AMPK signaling, smooth muscle cells were transfected with miRNA mimics and analyzed by western blot using phospho-specific antibodies. Since total levels of AMPK and ACC are reduced by the miR-144 and miR-451 mimics, phosphorylated AMPK and ACC levels were normalized to the stably expressed heat-shock protein 90 (HSP90) to reveal the full effect of the miRNA mimics.
After 72 hours of transfection, the cells were starved for 24 hours and then treated with the AMPK activator AICAR (1 mM) for 20 min. As expected, AICAR caused a significant increase of both AMPK phosphorylation at Thr172 and phosphorylation of its downstream target ACC at Ser79. Notably, the increase in AMPK phosphorylation by 1 mM AICAR was approximately 150% (Figure 3A) , which is in the same range as the increase caused by mechanical stretch ( Figure 1F ). Although miR-144 mimic was most effective in inhibiting AMPK phosphorylation, miR-451 mimic also prevented part of the AICAR-induced response ( Figure 3A) . As shown in Figure 3B , phosphorylation of ACC was reduced by miR-451 mimic in both basal conditions and after stimulation with AICAR, while miR-144 had a slightly smaller effect.
The activity of mTOR signaling, which is negatively regulated by AMPK, was measured by phosphorylation of its downstream target p70 ribosomal S6 kinase (p70S6K) at Thr389. As expected, AICAR treatment reduced p70S6K phosphorylation and we found that transfection of miR-451 mimic alleviated this inhibition ( Figure 3C ).
To test if the effect of miR-144/451 on AMPK phosphorylation correlated with an effect on AMPK activity, cells were treated with the combination of miR-144/451 according to the same protocol as in Figure 3A -C and analyzed by in vitro AMPK activity assay. As shown in Figure 3D and E, transfection of miR-144/451 mimic resulted in a small but significant decrease in AICAR-induced AMPKa1 and AMPKa2 activity.
AICAR-induced AMPK activation promotes contractile differentiation of vascular smooth muscle
Activation of AMPK has previously been implicated in the regulation of smooth muscle contractile differentiation [30] and it is well known that mechanical stretch of the vascular wall promotes the expression of smooth muscle markers [16, 17, 31] . In order to test if the level of AMPK-activation induced by mechanical stretch is sufficient to promote contractile differentiation, we stimulated isolated intact aorta ( Figure 4A ) and unstretched portal veins ( Figure 4B ) with 1 mM AICAR for 24 h in organ culture. The mRNA expression of known stretchsensitive smooth muscle markers such as calponin (Cnn1), desmin (Des), SM22 (Tagln), the BK channel b 1 -subunit (Kcnmb1) and myosin heavy chain (Myh11) was then analyzed by qPCR. AICAR promoted the expression of these smooth muscle markers to a similar or slightly higher extent compared to mechanical stretch of the portal vein (compare with Figure 4C ).
Discussion
In this study we investigated how the miRNA expression profile changes in response to stretch and tested the effect of stretchsensitive miRNAs on intracellular signaling in vascular smooth muscle. We show that miR-144/451 expression is significantly and specifically reduced in stretched portal veins and pressurized carotid arteries. Furthermore, we demonstrated that over-expression of these miRNAs affects the regulation of AMPK signaling by down-regulating total protein levels of MO25a, AMPKa and ACC. This effect resulted in inhibition of AICAR-induced We have previously demonstrated that miRNAs are essential for stretch-induced contractile differentiation, partly via reduction of L-type channel expression, which is likely due to increased expression of CamKIIä , a known target of miR-145 [17] . However, in that study we did not investigate the effect of stretch on miRNA expression and the role of stretch-induced miRNAs in intracellular signaling events in vascular smooth muscle. A number of specific miRNAs including miR-21 and miR-26a, and miR-153/223 have previously been demonstrated to be regulated by stretch in isolated and cultured vascular [32, 33] and airway smooth muscle cells [34] , respectively. Collectively, these miRNAs were shown to promote proliferation or hypertrophic growth of smooth muscle cells. Although studies in isolated cells are important to define the molecular mechanisms of stretch-induced signaling it is well known that tissue composition and contractile differentiation are essential factors for the mechanical properties of vascular smooth muscle. Therefore, stretch-induced effects also need to be investigated in systems in which the contractile phenotype and cell-matrix interactions are maintained. To our knowledge this is the first study investigating the effects of pressure and stretch on miRNA expression in intact vessels.
Since the turnover of miRNAs in quiescent smooth muscle is relatively slow, the effects on miR-144/451 observed in this study should be considered an early event in stretch-induced miRNA expression. MiR-144 and/or miR-451 have been studied previously in numerous cell types including erythrocytes [35, 36] , glioma cells [28] , cardiomyocytes [29, 37, 38] and smooth muscle cells [39] . In both glioma cells [28] and cardiomyocytes [29] , miR-451 has been demonstrated to target MO25a, an important regulator of the AMPK-signaling pathway [40] . We could confirm this effect in smooth muscle and also demonstrate that both miR-144 and miR-451 directly or indirectly target other mediators of the AMPK pathway including AMPK itself, and ACC.
AMPK activity is also regulated by phosphatases and miR-144 is predicted to target regulatory subunits of both protein phosphatase 1 (PP1) and protein phosphatase 2 (PP2). Although we did not investigate the role of PP1 and PP2 in the present study, we predict that it is unlikely that the inhibitory effect of miR-144 on AMPK activity is due to induction or activation of these phosphatases. In contrast, a reduced expression of the regulatory subunits of PP1 and PP2 by miR-144 would be expected to augment AMPK phosphorylation [41] .
To our knowledge, stretch-induced activation of AMPK in smooth muscle has not been demonstrated previously and thus represents a novel mechanism for smooth muscle mechanotransduction. Recent reports have shown that AMPK can be activated by Ang II [25] and inhibit the proliferative response to AngII in vascular smooth muscle cells. One can speculate that the activation of AMPK by stretch could act as a negative feedback mechanism to prevent excessive growth in response to stretch. This may have important clinical implications since deletion of AMPK exacerbates neointimal hyperplasia following vascular injury [26] while activation of AMPK by systemic or local delivery of AMPK activators like AICAR or A 769662, results in a significant reduction in neointimal area [27] . Future studies are needed in order to investigate if inhibition of miR144/451 in vascular smooth muscle cells can reduce neointimal hyperplasia via potentiation of AMPK signaling. Although AMPK is mostly recognized for its anti-proliferative effect in smooth muscle, it was recently demonstrated that AICAR-induced activation of AMPK could promote contractile differentiation of human coronary artery smooth muscle cells [30] . In accordance with that study, we found that AMPK activation promotes the contractile phenotype of smooth muscle cells in the unloaded portal vein to a similar extent as mechanical stretch.
In conclusion, our results demonstrate that stretch activates the AMPK signaling pathway and that stretch-sensitive miRNAs such as miR-144/451 can be involved in fine-tuning or long term control of this response. Furthermore, we show that AMPK activation, similar to stretch, can promote smooth muscle differentiation in both portal vein and aorta. AMPK activation may thus play a role in stretch-dependent contractile differentiation of vascular smooth muscle. 
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